Hepatitis C Clinic Presentations

Below is a list of past Hepatitis C ECHO Clinic presentations. To view presentation slides, presenter bios, and additional resources, click view more.


Simplified Hepatitis C Treatment | June 9, 2020

Annette Hewitt, an ARNP with the Liver Disease and Hepatitis Program at the Alaska Native Tribal Health Consortium, provides a simplified overview of HCV treatment.

Presenter: Annette Hewitt

View more >


HCV and People Who Inject Drugs | May 27, 2020

Dr. Jessica Gregg, Associate Professor of Medicine at OHSU, shares information on HCV in people who inject drugs, and medications used to treat opioid use disorder.

Presenter: Dr. Jessica Gregg

View more >


COVID-19 Infection and the Liver | April 14, 2020

Dr. Brian McMahon, Director of the Liver Disease and Hepatitis Program at the Alaska Native Tribal Health Consortium, talks about the differences in the underlying structure and pathogenicity of the different strains of coronavirus, how COVID-19 can involve the liver, the risk of severe complications in persons who acquire COVID-19 and have underlying liver disease, and medications that could potentially target the SARS-CoV-2 coronavirus.

Presenter: Dr. Brian McMahon

View more >


COVID-19 | March 25, 2020

Dr. Jorge Mera, Director of Infectious Diseases for Cherokee Nation Health Service, and Whitney Essex, Family Nurse Practitioner for Cherokee Nation Health Service, provide an overview on the epidemiology of COVID-19, share clinical examples and discuss potential treatments.

Presenters: Dr. Jorge Mera, Whitney Essex

View more >


Surveillance To Detect Hepatocellular Carcinoma | March 12, 2019

Incidence of hepatocellular carcinoma (HCC) is rising quickly in the United States, and AI/AN people are being affected greater than any other group. Dr. Brian McMahon, Director of the Liver Disease and Hepatitis Program at the Alaska Native Tribal Health Consortium, speaks about the importance of screening for HCC and catching it early, the type of patient to enroll in regular surveillance, and what kind of screening methodologies should be used.

Presenter: Dr. Brian McMahon

View more >


Addressing the Evolving Opioid and HCV Epidemics | February 27, 2019

Annette Hewitt, Nurse Practitioner for the Liver Disease and Hepatitis Program at the Alaska Native Tribal Health Consortium, explains parallels between the opioid and HCV epidemics. She also discusses harm reduction strategies that may be helpful and emphasizes the importance of treating people who inject drugs in order to effectively eliminate HCV.

Presenter: Annette Hewitt

View more >


Addiction Treatment and the HCV Provider | February 12, 2019

Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, discusses the relationship between the opioid epidemic and HCV infections as well as the different treatments available for those suffering from opioid use disorder.

Presenter: Dr. Jessica Gregg

View more >


HCV Elimination | January 23, 2019

Dr. Jorge Mera, Director of Infectious Diseases for the Cherokee Nation Health Service, provides a general overview of HCV elimination and micro-elimination, as well as an overview of the Cherokee Nation HCV Elimination Program.

Presenter: Dr. Jorge Mera

View more >


The Impact of SVR on Cirrhosis and Non-Liver Complications | December 11, 2018

Annette Hewitt and Lisa Townshend-Bulson, Family Nurse Practitioners from the Alaska Native Tribal Health Consortium, Liver Disease & Hepatitis Program, present on the impact of sustained virologic response (SVR) on cirrhosis and non-liver complications in both direct acting antiviral (DAA) and interferon-based treatments.

Presenters: Annette Hewitt, Lisa Townshend-Bulson

View more >


Opioid Substitution Therapy and the HCV-Provider | November 28, 2018

Dr. Aaron Skiles, a Family Nurse Practitioner with the UNM Sandoval Regional Medical Center, shares knowledge on the opioid epidemic, the merits of opioid substitution therapy, and the role of the HCV care provider in treating opioid use disorder.

Presenter: Dr. Aaron Skiles

View more >


HCV in Pregnant Women: How the Opioid Crisis is Changing the Landscape | September 26, 2018

Dr. Francheska Sevy Gurule, a Maternal Child Health Fellow at the University of New Mexico, Department of Family and Community Medicine, presents on the impact the opioid crisis has had on the prevalence of HCV in pregnant women.

Presenter: Dr. Francheska Sevy Gurule

View more >


Long Term Follow-Up After HCV Treatment | September 11, 2018

Dr. Paulina Deming, an Associate Professor of Pharmacy at the University of New Mexico Sciences Center, discusses the needed follow-up for patients with and without cirrhosis who have completed HCV treatment, including counseling on lifestyle changes to prevent reinfection.

Presenter: Dr. Paulina Deming

View more >


Addressing Transient Elastography (FibroScan): Integrating with HCV Care | Addressing Starting an HCV Clinic at Crow/Northern Cheyenne | August 25, 2018

Dr. Justin Iwasaki, the Executive Medical Director at Lummi Tribal Health Center (LTHC), discusses the creation and design considerations of the HCV Elimination Program at the LTHC, and then he provides an overview of FibroScan technology. Also, a team from the Crow/Northern Cheyenne Service Unit for Indian Health Service shares an overview of their HCV clinic, including why it was needed, how it was created, and their future goals.

Presenters: Dr. Justin Iwasaki, Dr. Kelsey Kroon, Dawn Benth, Dr. Angela Troutt

View more >


Addressing Transient Elastography (FibroScan): Integrating with HCV Care | August 14, 2018

Dr. Youssef Barbour, a Liver Specialist at the Alaska Native Medical Center, provides an overview of transient elastography (FibroScan) and the role that it can play in treating liver disease.

Presenter: Dr. Youssef Barbour

View more >


Addressing Barriers to Hepatitis C Care Faced By Individuals Who Use Drugs (Idaho, Oregon & Washington) | July 25, 2018

In these slides, Dr. Tina Broder from the National Viral Reduction Alliance, Dr. Vanessa McMahan from the People’s Harm Reduction Alliance, and Louise Vincent from the Urban Survivors Union, grade the states of Idaho, Oregon and Washington in their ability to provide hepatitis C care to individuals who use drugs.

Presenters: Dr. Tina Broder, Dr. Vanessa McMahan, Louise Vincent

View more >


Addressing Barriers to Hepatitis C Care Faced By Individuals Who Use Drugs (Alaska) | July 10, 2018

In these slides, Dr. Tina Broder from the National Viral Reduction Alliance, Dr. Vanessa McMahan from the People’s Harm Reduction Alliance, and Louise Vincent from the Urban Survivors Union, grade the state of Alaska in its ability to provide hepatitis C care to individuals who use drugs.

Presenters: Dr. Tina Broder, Dr. Vanessa McMahan, Louise Vincent

View more >


HCV Treatment in People Receiving MAT | June 25, 2018

In these slides, Dr. Jacob Kesner, an Infectious Diseases Pharmacist at Lovelace Medical Center, discusses the relationship between people receiving MAT and HCV treatment, shares his rationale for providing HCV treatment to people receiving MAT and offers best practices for providing treatment in those cases.

Presenter: Dr. Jacob Kesner

View more >


HCC Screening and Follow-Up | May 23, 2018

In these slides, Dr. Pippa Newell, Medical Director of the Liver Cancer Program at the Providence Cancer Center, shares information on the rising number of cases of hepatocellular carcinoma in the U.S. and Indian Country, the advantages and failings of HCC screenings, and best practices for patient follow-up.

Presenter: Dr. Pippa Newell

View more >


HCV and Children | ANTHC Rural Alaska Harm Reduction Initiative | May 8, 2018

Jacqueline Fridge, the Division Chief of Pediatric Gastroenterology, Hepatology and Nutrition at the University of New Mexico, discusses the prevalence of HCV in children and screening options for children and youth. She also shares ways HCV can be transmitted to youth and describes when and how to treat them. Then, Cornelia Jessen, the STD Program Manager at the Alaska Native Health Consortium, shares information on the Alaska Native Tribal Health Consortium’s efforts to extend the reach of harm reduction for people with substance use disorders in rural Alaska.

Presenters: Jacqueline Fridge, Cornelia Jessen

View more >


Hepatitis C Linkage to Care | April 25, 2018

Greg Carlson, a Nurse with United Indian Health Services, shares detailed information and strategies for retaining HCV patients in care until they have reached a cure.

Presenter: Greg Carlson

View more >


Considerations for Age Expanded Hepatitis C Testing: 2018 | April 10, 2018

Dr. Brian McMahon, Director of the Liver Disease and Hepatitis Program at ANTHC, discusses the epidemiology of HCV, who should be screened to detect chronic HCV infection, and the potential of screening beyond CDC recommendations.

Presenter: Dr. Brian McMahon

View more >


Liver Fibrosis Staging | Cherokee Nation Health Services HCV Elimination Program | March 28, 2018

In the first set of slides, Dr. Paulina Deming, Associate Professor of Pharmacy at the University of New Mexico Sciences Center, describes the stages of hepatitis C related liver disease and identifies non-invasive liver fibrosis staging methods. In the second set of slides, Dr. Jorge Mera, Director of Infectious Diseases for Cherokee Nation Health Service, provides an overview of the HCV Elimination Program at Cherokee Nation.

Presenters: Dr. Paulina Deming, Dr. Jorge Mera

View more >


Cherokee Nation Health Services HCV Elimination Program | March 13, 2018

Dr. Jorge Mera provides an overview of the HCV Elimination Program at Cherokee Nation.

Presenter: Dr. Jorge Mera

View more >


The Language of Addiction | HCV Epidemiology | February 28, 2018

In these slides, Dr. Karla Thornton, Professor of Infectious Diseases at the UNM Health Sciences Center, discusses the importance of using non-stigmatizing language when talking about substance use disorders. Dr. Thornton also provides an overview of  language that has been recommended by the Office of National Drug Control Policy. Brigg Reilley, HIV/HCV National Programs Epidemiologist at the Northwest Portland Area Indian Health Board, shares information about the epidemiology of HCV in the Great Plains region.

Presenters: Dr. Karla Thornton, Brigg Reilley

View more >


Home Outreach for HCV Care | January 24, 2018

Dr. Kimberly Suk, an Internal Medicine Specialist at Gallup Indian Medical Center, shares the steps taken at Gallup to create a home outreach HCV program. Dr. Suk also discusses program outcomes and proposed plans for the program.

Presenter: Dr. Kimberly Suk

View more >


Starting a HCV Program – Belcourt | December 14, 2017


LCDR Jonathan Owen and LT Neelam Gazarian, Pharmacists with the Indian Health Service, share the tools used to manage complex care and start an HCV program in the area of Belcourt, North Dakota.

Presenters: LCDR Jonathan Owen, LT Neelam Gazarian

View more >


Accessing Meds, State of Medicaid and Patient Management Tools | November 22, 2017

LCDR Jonathan Owen and LT Neelam Gazarian, Pharmacists with the Indian Health Service, discuss the challenges of accessing medications through medicaid and how providers can assist, and share some valuable patient management tools for HCV clinics.

Presenters: Dr. Jonathan Owen, Dr. Neelam Gazarian

View more >


Interview Project with People Who Inject Drugs, Community and Health Care Staff to Explore Community-Driven Education, Prevention and Healthcare Systems Improvement | October 25, 2017

These slides describe the results of an interview project with people who inject drugs, their community and healthcare staff. They describe the rationale for treating HCV in people who inject drugs and identify the best treatment practices. They also discuss patient centered communication when working with people who inject drugs.

Presenter: Jessica Leston

View more >


HCV Treatment in Injection Drug Users | September 27, 2017

In these slides, Dr. Jacob Kesner, an Infectious Diseases Pharmacist at Lovelace Medical Center, discusses the relationship between HCV and people who inject drugs. He then describes the rationale for treating in HCV in people who inject drugs and identifies the best practices for doing so.

Presenter: Dr. Jacob Kesner

View more >


Syringe Services and HCV Treatment at Lummi Tribal Health Center | August 23, 2017

Jessica Rienstra, Hepatitis C Project Coordinator at Lummi Tribal Health Center (LTHC), provides an overview of the syringe services and HCV treatment program at LTHC.

Presenter: Jessica Rienstra

View more >


Hepatitis C Screening and Assessment | July 26, 2017

CAPT Stephen Rudd, Chief Medical Officer and Deputy Director of the Portland Area Indian Health Service, provides an overview of HCV screening and assessment procedures, risk factors, and tools.

Presenter: Dr. Stephen Rudd

View more >


Hepatitis C Mortality Among American Indians and Alaskan Natives in the Northwest, 2006-2012 | June 28, 2017

These slides present data related to HCV mortality among the AI/AN population in the Northwest. Slides accompany written report.

Presenter: Dr. Sarah Hatcher

View more >


Hepatocellular Carcinoma: Diagnosis and Management | May 24, 2017

Dr. Pippa Newell, Medical Director of the Liver Cancer Program at the Providence Cancer Center, shares several HCC case studies and discusses diagnosis and management of HCC patients.

Presenter: Dr. Pippa Newell

View more >


Hepatocellular Carcinoma: Screening and Diagnosis | April 26, 2017

Dr. Pippa Newell, Medical Director of the Liver Cancer Program at the Providence Cancer Center, discusses who and why providers should screen for HCC. Dr. Newell also shares recommendations for diagnostic methods.

Presenter: Dr. Pippa Newell

View more >


Alternative (Non FDA Approved) Treatments for Alcohol Use Disorder | April 19, 2017

Part 4 of 4. Shanna Diaz, Assistant Professor of Sleep Medicine at the University of New Mexico, reviews alternative pharmacotherapy treatments for alcohol use disorder, the use of these medications in patients with hepatitis C and their most common and serious side effects.

Presenter: Shanna Diaz

View more >


HCV Epidemiology | March 22, 2017

In these slides, Brigg Reilley, HIV/HCV National Programs Epidemiologist at the Northwest Portland Area Indian Health Board, shares HCV epidemiological data comparing western IHS clinic data to other clinics across Indian Country.

Presenter: Brigg Reilley

View more >


FDA Approved Treatments for Alcohol Use Disorder | March 15, 2017

Part 3 of 4. Shanna Diaz, Assistant Professor of Sleep Medicine at the University of New Mexico, reviews the FDA approved drugs for treating alcohol use disorder, the use of these medications within patients with HCV and their most common and serious side effects.

Presenter: Shanna Diaz

View more >


Ways to Have Alcohol Use Disorder | March 1, 2017

Part 2 of 4. Shanna Diaz, Assistant Professor of Sleep Medicine at the University of New Mexico, discusses the subtypes of alcohol use disorder, how different patient characteristics impact different types of alcohol use patterns and how those choices may impact treatment choices and prognosis.

Presenter: Shanna Diaz

View more >


ECHO Overview and Liver Fibrosis Staging | February 22, 2017

These slides contain an overview of the HCV teleECHO program. Then, Dr. Jorge Mera, Director of Infectious Diseases for Cherokee Nation Health Service, discusses liver fibrosis staging and why it is important.

Presenter: Dr. Jorge Mera

View more >


Alcohol Use Disorder | January 18, 2017

Part 1 of 4. Shanna Diaz, Assistant Professor of Sleep Medicine at the University of New Mexico, provides an overview of alcohol use disorder and its medical and societal impact.

Presenter: Shanna Diaz

View more >